SCHEMBL14885231

SCHEMBL14885231

Cc1cccc(CS(=O)(=O)Nc2ccnc(C(=O)NO)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ANO1 Q5XXA6 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ GRM4 Q14833 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.46
▸ ACLY P53396 1/20 0.45
▸ TTK P33981 1/20 0.45
▸ MMP13 P45452 1/20 0.44
▸ HDAC1 Q13547 2/20 0.43
▸ ALKBH2 Q6NS38 1/20 0.42
▸ ALKBH3 Q96Q83 1/20 0.42
▸ FTO Q9C0B1 1/20 0.42
▸ PSEN1 P49768 1/20 0.41
▸ PSEN2 P49810 1/20 0.41
▸ APH1B Q8WW43 1/20 0.41
▸ NCSTN Q92542 1/20 0.41
▸ APH1A Q96BI3 1/20 0.41
▸ PSENEN Q9NZ42 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14882674 0.87 HDAC1 (0.44) ANO1ALDH1A1HPGDKDM4EPOLB
SCHEMBL14875894 0.87 HDAC1 (0.56) ALDH1A1HPGDKDM4EPOLBMMP13
SCHEMBL14882770 0.86 ANO1 (0.50) ANO1ALDH1A1GRM4POLBHDAC8
Hydrochloric Acid SCHEMBL14876074 0.86 HDAC1 (0.43) ANO1ALDH1A1HPGDKDM4EPOLB
SCHEMBL14882660 0.86 ANO1 (0.50) ANO1ALDH1A1HPGDKDM4EGRM4
Hydrochloric Acid SCHEMBL14876023 0.85 ANO1 (0.49) ANO1ALDH1A1HPGDKDM4EGRM4
Hydrochloric Acid SCHEMBL14875798 0.85 ANO1 (0.49) ANO1ALDH1A1GRM4POLBHDAC8
SCHEMBL14882680 0.84 ANO1 (0.49) ANO1GRM4HDAC8MMP13HDAC1
Hydrochloric Acid SCHEMBL14876068 0.83 ANO1 (0.48) ANO1GRM4HDAC8MMP13HDAC1
SCHEMBL14882665 0.81 ANO1 (0.49) ANO1ALDH1A1GRM4POLBHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102601-A1 Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease F. HOFFMANN-LA ROCHE LTD (CH) 2013-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102601-A1 Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease TPMT, TYMP, HPRT1 ANO1 3256/4885ALDH1A1 609/4885HPGD 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback